Healthcare
Ear Disorder Venture – SUCCESS PAGE – June 25, 2026
EDV is developing a non-invasive drug delivery platform to transport therapeutics directly to the inner ear via ear drops
EDV is developing a non-invasive drug delivery platform to transport therapeutics directly to the inner ear via ear drops
Nexscient transforms real-world human actions into structured training datasets designed for humanoid robots and Vision-Language-Action models.
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
EDV is developing a non-invasive drug delivery platform to transport therapeutics directly to the inner ear via ear drops
Vessel Wave Technologies is addressing a large and growing cardiovascular issue with the first aortic stent-graft designed to mimic the natural elasticity of the aorta
The first company to deliver the true cold coffee experience to homes, hotels, restaurants, and every other place where people enjoy coffee
Myris Therapeutics is revolutionizing the delivery of small molecule cancer therapies with its HiDAR Precision Medicine Platform
Ticonderoga Strategic Event Fund focuses event-driven opportunities and mispriced situations created by today’s improving M&A landscape
troCarWash has the potential to shorten operation times, improve outcomes, and reduce costs
Vessel Wave Technologies is addressing a large and growing cardiovascular issue with the first aortic stent-graft designed to mimic the natural elasticity of the aorta
The first company to deliver the true cold coffee experience to homes, hotels, restaurants, and every other place where people enjoy coffee